WO2006114051A1 - Dispositif pour controler le diabete - Google Patents

Dispositif pour controler le diabete Download PDF

Info

Publication number
WO2006114051A1
WO2006114051A1 PCT/CN2006/000777 CN2006000777W WO2006114051A1 WO 2006114051 A1 WO2006114051 A1 WO 2006114051A1 CN 2006000777 W CN2006000777 W CN 2006000777W WO 2006114051 A1 WO2006114051 A1 WO 2006114051A1
Authority
WO
WIPO (PCT)
Prior art keywords
blood glucose
diabetes
module
knowledge base
blood
Prior art date
Application number
PCT/CN2006/000777
Other languages
English (en)
French (fr)
Inventor
Hou-Mei Henry Chang
Original Assignee
Hou-Mei Henry Chang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US11/919,374 priority Critical patent/US20090312620A1/en
Application filed by Hou-Mei Henry Chang filed Critical Hou-Mei Henry Chang
Publication of WO2006114051A1 publication Critical patent/WO2006114051A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00—Subject matter not provided for in other main groups of this subclass

Definitions

  • the invention relates to a device for providing information on diabetes conditions, in particular to a diabetes monitor. Background technique
  • diabetes The prevention and treatment of diabetes is a major health problem in society. According to the World Health Organization, as of 2003, 40 million people in China had diabetes, and the number of patients was still increasing at a high rate. The serious risk of diabetes is the various complications caused by the later stages such as cardiovascular and cerebrovascular diseases, retinopathy, kidney disease, stroke and even amputation. So far, diabetes has not been completely cured, but through effective monitoring to achieve comprehensive treatment of diet, exercise and drugs, the condition can be controlled. The World Health Organization and all doctors have repeatedly stressed that it is important for patients to monitor themselves on a regular basis.
  • blood glucose detectors are used as monitoring tools for diabetes at home and abroad.
  • the patient measures the blood sugar value through the blood glucose tester, and takes corresponding control or treatment according to the blood sugar level, which is undoubtedly helpful for diabetic patients.
  • the level and severity of diabetes in patients is not determined by a single blood glucose level in most cases.
  • the degree of diabetes often depends on different blood glucose data. If you do not consider all kinds of blood glucose data, only measure one blood glucose value alone and use it as the basis for disease judgment. Not only can you not accurately determine the level of diabetes, but sometimes even cause illusion, thus delaying the timing of treatment and causing greater impact on patients. hurt.
  • measuring the patient's blood glucose level is only a means, and it is the purpose of the patient to understand the level of diabetes by measuring the blood glucose level, so as to achieve the patient's self-monitoring and effective control of the condition.
  • the object of the present invention is to provide a diabetes monitor which enables a patient to directly obtain information on the condition of diabetes by measuring blood sugar, thereby realizing real monitoring of diabetes.
  • a quantitative reference is provided for the accurate understanding of the patient's level and severity of the disease and the targeted treatment.
  • the technical scheme of the diabetes monitor of the invention is:
  • a diabetes monitor includes an input module, a storage module and a knowledge base system module, which are sequentially connected, and the storage module receives one or more blood glucose values of the patient from the input module, stores them separately according to categories, and sends them to the knowledge base system.
  • a module the knowledge base system module inferring diabetes condition information based on the one or more blood glucose values.
  • the input module is a blood glucose detecting device that measures a blood sugar level of a patient.
  • the knowledge base system module is further coupled to the display module for displaying the array of blood glucose values and/or the diabetes condition information.
  • the blood glucose value array is composed of different types of blood glucose values, and the categories are classified according to sampling mode and/or sampling time; the sampling methods are venous blood sampling and capillary blood sampling, and the sampling time is fasting blood glucose and postprandial 2 hours of blood sugar, 2 hours of blood sugar after drinking sugar and random blood sugar.
  • the knowledge base system module includes a receiving unit, an inference unit and a sending unit connected in sequence, and the inference unit is further connected to the diabetes knowledge base;
  • the diabetes knowledge base is an array reflecting the correspondence between the blood glucose level of the model and the diabetic condition, the diabetes
  • the knowledge base may be a two-dimensional array composed of individual components, each component of the array reflects a correspondence between a set of model blood glucose values and a diabetic condition;
  • the receiving unit receives and stores each blood glucose value of the module, and the inference unit Searching each component of the two-dimensional array of the diabetes knowledge base and comparing with the received data, finding the component closest to the received value to obtain the diabetes condition information corresponding to the received data, and sending the information to the display module for display and/or
  • the storage module is stored.
  • a diabetes monitor includes an input module, a storage module, a data transmission module and a display module, which are sequentially connected, and the storage module receives a blood glucose value of the patient from the input module, stores it according to a category, and sends the data to the data transmission module;
  • the module also connects to the knowledge base system module of the peripheral through data communication, sends the blood glucose value to the knowledge base system module, and receives the diabetes condition information from the knowledge base system module.
  • the input module is a blood glucose detecting device that measures a blood sugar level of a patient.
  • the storing by category refers to an array of blood glucose values composed of different types of blood glucose values, the categories being classified by sampling method and/or by sampling time; the sampling methods are venous blood sampling and capillary blood sampling, and the sampling time is Fasting blood glucose, 2 hours postprandial blood glucose, 2 hours post-sugar blood glucose and random blood glucose, the so-called random blood glucose refers to the blood glucose level measured at any time other than the above three blood glucose.
  • the knowledge base system module of the peripheral device comprises a receiving unit, an inference unit and a sending unit connected in sequence, and the inference unit is further connected to the diabetes knowledge base; the diabetes knowledge base is a second reflecting the correspondence between the blood glucose value array and the diabetes condition of the model.
  • the receiving unit receives an array of blood glucose values of the data transmission module
  • the inference unit searches a two-dimensional array of the diabetes knowledge base and compares the data with the data, and finds the blood glucose value of the model with the closest value to obtain the blood glucose value corresponding to the blood glucose value.
  • the diabetes condition information is sent to the display module display and/or the storage module for storage via the data transmission module.
  • the data transmission module is a wireless communication terminal, a network communication terminal, and/or a data interface.
  • the invention realizes the diabetes condition information by storing the blood sugar value array and setting the knowledge base system module, and realizes The patient's accurate monitoring of diabetes.
  • the technical scheme of the diabetes monitor of the invention breaks through the design concept of the traditional blood glucose monitor, and rises from blood glucose monitoring to diabetes monitoring, and this is exactly in line with the needs of society and patients.
  • monitoring blood glucose levels is not an end, but understanding the level of diabetes through blood glucose measurements is the essence of patient care.
  • the patient's blood glucose level and its level of diabetes are not completely linear, so the measurement of blood glucose can not fully realize the patient's understanding of the disease, and the level of diabetes is also determined by a blood glucose value alone.
  • One-sidedness is provided to determine the blood glucose value alone.
  • the diabetes monitor of the invention directly displays the information of the patient's diabetes condition, so that the patient takes timely and necessary control or treatment means on the basis of understanding the level of the diabetes condition, that is, effectively controls the condition, and has great recovery for the patient. s help.
  • Figure 1 is a schematic structural view of the present invention
  • FIG. 3 is a schematic structural diagram of another technical solution of the present invention. detailed description
  • the diabetes monitor of the present invention comprises an input module 11 , a storage module 12 , a knowledge base system module 13 and a display module 14 , which are sequentially connected.
  • the knowledge base system module 13 includes a receiving unit 133 and an inference unit which are sequentially connected. 131 and transmitting unit 134, the inference unit 131 is also connected to the diabetes knowledge base 132.
  • the input module 11 is responsible for transmitting the patient's blood glucose value to the storage module 12 for storage.
  • the input module 11 can be a blood sugar detecting device, an input device or a data interface.
  • the input module 11 of the preferred embodiment is a blood sugar detecting device that directly measures the blood sugar level of the patient, such as various blood glucose detecting devices that are commercially available. After the blood glucose detecting device measures the blood sugar level of the patient, the data is sent to the storage module 12. Of course, this can also be done using a keyboard (input device) or a data line (data interface).
  • the blood glucose value stored by the storage module 12 is an array of blood glucose values, and the blood glucose value array is composed of different types of blood glucose values.
  • the blood glucose level of the patient is classified according to sampling mode and/or sampling time.
  • the sampling method is divided into venous blood sampling and capillary blood sampling.
  • the sampling time is divided into fasting blood glucose, 2 hours postprandial blood glucose, and after taking sugar. 2 hours of blood sugar and random blood sugar.
  • the blood glucose level array is an array in which the above various blood glucose values are arbitrarily combined and arranged in a set format.
  • an array format blood glucose level can be set to [sampling mode, fasting glucose, 2-hour postprandial blood glucose 2 hours after oral glucose glucose, random blood glucose], or set to [fasting blood glucose, blood glucose 2 hours after oral glucose] Wait.
  • the storage mode of the storage module 12 is different from the storage method of the single blood glucose value used by the existing blood glucose monitor, and the blood glucose level of the different types can be accurately reflected in the patient's diabetes state.
  • the knowledge base system module 13 receives the blood glucose value array stored by the storage module 12, and infers the corresponding diabetes condition information. Specifically, it produces five kinds of condition results such as normal blood sugar, hypoglycemia, impaired glucose tolerance, impaired fasting blood glucose, or diabetes.
  • the above five kinds of disease results basically reflect the severity of diabetes, and have direct guiding effect on patients' understanding of the disease and corresponding treatment.
  • Knowledge base module 13 includes a receiving unit 133 are connected in sequence, and the inference unit 1_31 transmitting unit 134, the inference unit 131 is also connected to knowledge base 132 of diabetes.
  • the diabetes knowledge base 132 is a two-dimensional array reflecting the correspondence between the template blood glucose value array and the diabetes condition
  • the receiving unit 133 receives the blood glucose value array of the storage module 12
  • the inference unit 131 searches the two-dimensional array of the diabetes knowledge base 132. And comparing with the data, the model blood sugar value closest to the value is found to obtain the diabetes condition information corresponding to the blood sugar value, and the sending unit 134 sends the information to the display module 14 display and/or the storage module 12 for storage.
  • the diabetes knowledge base 132 stores a two-dimensional array of templates relating to blood glucose values and diabetes conditions.
  • the two-dimensional array of the model is based on the criteria for determining the condition of diabetes, which is the latest diabetes standard recognized and issued by the World Health Organization (WHO) and the Chinese Diabetes Association, published in the 2002 Asia Pacific Type 2 Diabetes Policy Group. Edited and published in the "Practical Targets and Treatment of Type 2 Diabetes".
  • WHO World Health Organization
  • the manual approved by the China Diabetes Association and translated and published, is the latest authoritative document on diabetes.
  • the present invention refers to the criterion and performs reasonable arrangement and combination.
  • the sampling method is divided into venous blood sampling and capillary blood sampling.
  • the sampling time is divided into fasting blood glucose, 2 hours postprandial blood glucose, 2 hours after taking sugar, and blood glucose.
  • each blood sugar value is divided into 4 to 5 numerical ranges, resulting in more than 400 blood sugar value combinations.
  • the present invention screens out nearly 100 blood sugar value combinations with practical value, and 5 types of diabetes disease information summarized according to the above combination. Therefore, the two-dimensional array of the template is composed of an array of nearly 100 blood glucose levels and five types of diabetes condition information.
  • the inference unit 131 searches for a blood glucose value of the closest two-dimensional array of the model corresponding to the blood glucose value array for each set of the blood glucose value array, thereby obtaining the corresponding diabetes condition information.
  • the present invention adds supplementary data information based on the above five kinds of condition information.
  • information such as "insufficient information” or "should be supplemented with blood glucose values” is given.
  • the inference unit 131 receives an array of blood glucose values: fasting blood glucose 6.6 fiber. 1/1, blood glucose of 8. 5 mmol/l after 2 hours of meal, because the blood glucose value array data is insufficient, the inference unit 131 gives a prompt of "2 hours of data after taking the sugar". If the blood glucose value array received by the inference unit 131 is ' ⁇ fasting blood glucose 6.
  • the workflow can further illustrate the technical solution of the knowledge base system module 13.
  • the knowledge base system module 13 can be implemented by a hardware chip or a software program, and the preferred solution uses a single-chip MCU. With the powerful functions of the MCU of the single chip microcomputer, the present invention can also implement other functions, such as:
  • FIG. 3 is a schematic structural view of another technical solution of the diabetes monitor of the present invention.
  • the diabetes monitor of the present invention includes an input module 11, a storage module 12, a data transmission module 24, and a display module 14, which are sequentially connected.
  • the input module 11 is responsible for collecting the patient's blood glucose level and sending it to the storage module 12 for storage.
  • the input module 11 can employ conventional blood glucose detecting devices such as various blood glucose detecting devices available on the market.
  • the blood glucose value stored in the storage module 12 is an array of blood glucose values, and the blood glucose value array is composed of blood glucose values of different categories.
  • the blood glucose level of the patient is classified according to sampling mode and/or sampling time.
  • the sampling method is divided into venous blood sampling and capillary blood sampling.
  • the sampling time is divided into fasting blood glucose, 2 hours postprandial blood glucose, and after taking sugar. 2 hours of blood sugar and random blood sugar.
  • the blood glucose level array is an array in which the above various blood glucose values are arbitrarily combined and arranged in a set format.
  • the core of the technical solution of the present invention is to provide a data transmission module connected to the storage module 12 and the display module 14.
  • the data transmission module 24 is connected to the knowledge base system module 13 of the peripheral by data communication.
  • the data transmission module 24 transmits the blood glucose value array received from the storage module 12 to the knowledge base system module 13 while receiving the diabetes condition information from the knowledge base system module 13 and transmitting it to the display module 14 for display and/or to the storage module 12 for storage.
  • the technical solution of the present invention is different from the foregoing technical solution in that the knowledge base system module 13 of the present invention is disposed externally, and establishes an information transfer relationship with the data transmission module 24 through data communication. '
  • the structure and working principle of the knowledge base system module 13 of the peripheral device are basically the same as the foregoing, and the diabetes condition information includes normal blood sugar, low blood sugar, low glucose tolerance, impaired fasting blood glucose and diabetes.
  • the data transmission unit 24 can be a wireless communication terminal or a network communication terminal or a data interface.
  • the wireless communication terminal refers to a device that uses a mobile communication network for data transmission, and refers to a short message terminal, such as a mobile phone.
  • the short message terminal and the knowledge base system module 13 are interconnected by the mobile communication network, and the short message terminal sends the blood glucose value array to the knowledge base system module 13 in a short message manner, and after the knowledge base system module 13 performs the inference and judgment,
  • the diabetes condition information is also sent back to the short message terminal in a short message manner, and the short message terminal transmits the diabetes condition information to the display module 14 for display and/or to the storage module 12 for storage.
  • the network communication terminal refers to a device that uses an INTERNET network for data transmission, and refers to an instant communication terminal, such as a notebook.
  • the instant messaging terminal and the knowledge base system module 13 are interconnected by the INTERNET network, and the instant messaging terminal sends the blood glucose value array to the knowledge base system module 13 in an instant message manner, the knowledge base system After the inference reasoning, the system 13 sends the diabetes condition information to the instant messaging terminal in the instant message manner, and the instant messaging terminal transmits the diabetes condition information to the display module 14 for display and/or to the storage module 12 for storage.
  • the instant messaging is a process of sending and receiving instant messages between end users of a computer network, such as Microsoft Corporation MSN.
  • the above functions can also be implemented by using the Email method.
  • the data interface refers to a device that directly exchanges data with a computer, such as an I/O interface.
  • the computer storing the knowledge base system module 13 receives the blood glucose value array through the I/O interface, and after the knowledge base system module 13 performs the inference determination, the diabetes condition information is also sent back to the display through the I/O interface.
  • Module 14 is displayed and/or transferred to storage module 12 for storage.

Description

糖尿病监测仪
技术领域
本发明涉及一种提供糖尿病病情信息的装置， 特别是一种糖尿病监测仪。 背景技术
糖尿病的预防与治疗是目前社会一个重大的卫生问题。 据世界卫生组织报道， 截止 2003年， 我国已有 4000万人患有糖尿病， 并且患病人数还在高速增加。糖尿病的严重危 害在于后期引起的各种并发症如心脑血管病变、 视网膜病变、 肾病、 中风甚至截肢。 到 目前为止， 糖尿病还没有彻底根治的办法， 但通过有效监测达到饮食、 运动和药物的综 合治疗， 病情是可以控制的。 世界卫生组织和所有医生都一再强调， 患者平时自我监测 是十分重要的。
目前国内外均采用血糖检测仪作为糖尿病的监测工具。 患者通过血糖检测仪测出血 糖值， 根据该血糖值采取相应的控制或治疗手段， 这无疑对糖尿病患者有一定帮助。 但 患者糖尿病病情的水平和严重程度在多数情况下并不是由单一血糖值确定的， 糖尿病的 病情程度往往取决于不同的血糖数据。 如果不综合考虑各种血糖数据， 仅单独测量一种 血糖值并以此作为病情判断依据， 不仅不能准确判断糖尿病的病情水平， 有时甚至会造 成假象， 从而延误治疗时机， 给患者造成更大的伤害。
因此， 测量患者的血糖值只是一种手段， 而通过血糖值测量使患者了解其糖尿病病 情水平才是目的， 才能实现患者自我监测、 有效控制病情的治疗目的。 发明内容
本发明的目的是提供一种糖尿病监测仪， 使患者通过测量血糖即可直接获得其糖尿 病病情信息， 实现了对糖尿病病情的真正监测。 对患者准确了解病情水平和严重程度， 有针对性地釆取治疗手段提供了定量的参考。
本发明糖尿病监测仪的技术方案为：
一种糖尿病监测仪， 包括依次连接的输入模块、 储存模块和知识库系统模块， 所述 储存模块从输入模块接收患者一种或一种以上血糖值， 按类别分别储存， 并发送给知识 库系统模块， 所述知识库系统模块根据所述一种或一种以上血糖值推理出糖尿病病情信 息。 所述输入模块为测定患者血糖值的血糖检测装置。
所述知识库系统模块还连接显示模块，显示所述血糖值数组和 /或所述糖尿病病情信 息。
所述血糖值数组由不同类别的血糖值组成，所述类别为按取样方式和 /或按取样时间 分类； 所述取样方式为静脉取血和毛细血管取血， 取样时间为空腹血糖、 餐后 2小时血 糖、 服糖后 2小时血糖和随机血糖。
所述知识库系统模块包括依次连接的接收单元、 推理单元和发送单元， 推理单元还 连接糖尿病知识库； 所述糖尿病知识库为反映模本血糖值与糖尿病病情间对应关系的数 组， 所述糖尿病知识库可以是由各个组元组成的二维数组， 该数组中每一组元反映一组 模本血糖值与糖尿病病情间对应关系； 所述接收单元接收并储存模块的各血糖值， 推理 单元搜索所述糖尿病知识库的二维数组的每一组元并与接收数据进行比对， 找到与接收 数值最接近的组元从而得到接收数据对应的糖尿病病情信息，发送到显示模块显示和 /或 存储模块储存。
本发明糖尿病监测仪的另一技术方案为：
一种糖尿病监测仪， 包括依次连接的输入模块、 储存模块、 数据传输模块和显示模 块， 所述储存模块从输入模块接收患者血糖值， 按类别储存， 并发送给数据传输模块； 所述数据传输模块还通过数据通讯与外设的知识库系统模块连接， 向知识库系统模块发 送血糖值， 同时从知识库系统模块接收糖尿病病情信息。
所述输入模块为测定患者血糖值的血糖检测装置。
所述按类别储存是指由不同类别的血糖值组成血糖值数组， 所述类别为按取样方式 和 /或按取样时间分类；所述取样方式为静脉取血和毛细血管取血，取样时间为空腹血糖、 餐后 2小时血糖、 服糖后 2小时血糖和随机血糖， 所谓随机血糖是指除去前述三种血糖 外任何时间测出的血糖值。
所述外设的知识库系统模块包括依次连接的接收单元、 推理单元和发送单元， 推理 单元还连接糖尿病知识库； 所述糖尿病知识库为反映模本血糖值数组与糖尿病病情间对 应关系的二维数组， 所述接收单元接收数据传输模块的血糖值数组， 推理单元搜索所述 糖尿病知识库的二维数组并与其数据进行比对， 找到数值最接近的模本血糖值从而得到 该血糖值对应的糖尿病病情信息，通过数据传输模块发送到显示模块显示和 /或存储模块 储存。
所述数据传输模块为无线通讯终端、 网络通讯终端和 /或数据接口。
本发明通过储存血糖值数组和设置知识库系统模块推理出糖尿病病情信息， 实现了 患者对糖尿病病情的准确监测。 本发明糖尿病监测仪的技术方案突破了传统血糖监测仪 的设计理念， 从血糖值监测上升为糖尿病病情监测， 而这一点正好完全符合社会和患者 的需求。 对于患者来说， 监测血糖值不是目的， 而通过血糖值的测量了解其糖尿病病情 水平才是患者关心的实质。 实际上， 患者血糖值与其糖尿病病情水平之间不完全是简单 的线形关系， 因此血糖值的测量不能完全实现患者对其病情的了解， 且单独依据一种血 糖值判定患者糖尿病病情水平也存在相当的片面性。 本发明糖尿病监测仪实现了直接显 示患者糖尿病病情信息， 使患者在了解其糖尿病病情水平的基础上， 采取及时、 必要的 控制或治疗手段， 即有效地控制了病情， 又对患者的康复有巨大的帮助。 附图说明
图 1为本发明结构示意图；
图 2为本发明知识库系统模块工作流程图;
图 3为本发明另一技术方案结构示意图。 具体实施方式
下面结合附图详细说明本发明的技术方案。
图 1为本发明糖尿病监测仪的结构示意图。 如图 1所示， 本发明糖尿病监测仪包括 依次连接的输入模块 11、 储存模块 12、 知识库系统模块 13和显示模块 14, 所述知识库 系统模块 13包括依次连接的接收单元 133、推理单元 131和发送单元 134，推理单元 131 还连接糖尿病知识库 132。
输入模块 11负责将患者血糖值发送到储存模块 12储存。所述输入模块 11可以是血 糖检测装置、 录入装置或数据接口。优选方案的输入模块 11为直接测定患者血糖值的血 糖检测装置， 如市场上销售的各种血糖检测仪。 血糖检测装置测定患者血糖值后， 将数 据发送到储存模块 12。 当然， 使用键盘 （录入装置） 或数据线 （数据接口） 也可以完成 上述工作。
储存模块 12所储存的血糖值是血糖值数组，所述血糖值数组是由不同类别的血糖值 组成。 在本实施例中， 患者的血糖值按取样方式和 /或按取样时间分类， 取样方式分为静 脉取血和毛细血管取血， 取样时间分为空腹血糖、 餐后 2小时血糖、 服糖后 2小时血糖 和随机血糖。 具体地说， 血糖值数组是由上述各种血糖值任意组合、 按设定格式排列的 数组。 例如， 血糖值数组的格式可以设定为 [取样方式， 空腹血糖， 餐后 2小时血糖， 服 糖后 2小时血糖， 随机血糖]， 或设定为 [空腹血糖， 服糖后 2小时血糖]等。 显然， 本发 明储存模块 12的储存方式不同于现有血糖监测仪采用的单一血糖值的存储方式，通过多 种不同类别的血糖值， 才能准确反映患者的糖尿病状态。
知识库系统模块 13接收储存模块 12存储的血糖值数组， 推理出对应的糖尿病病情 信息。 具体地说， 生成血糖正常、 低血糖、 糖耐量低减、 空腹血糖受损或糖尿病等 5种 病情结果。 上述 5种病情结果基本反映了糖尿病病情的严重程度， 对患者认识病情和采 取相应治疗具有直接的指导作用。
知识库系统模块 13包括依次连接的接收单元 133、 推理单元 1_31和发送单元 134， 推理单元 131还连接糖尿病知识库 132。所述糖尿病知识库 132为反映模本血糖值数组与 糖尿病病情间对应关系的二维数组， 接收单元 133接收储存模块 12的血糖值数组， 推理 单元 131搜索所述糖尿病知识库 132的二维数组并与其数据进行比对， 找到数值最接近 的模本血糖值从而得到该血糖值对应的糖尿病病情信息， 发送单元 134将信息发送到显 示模块 14显示和 /或存储模块 12储存。
糖尿病知识库 132存储了关于血糖值与糖尿病病情对应关系的模本二维数组。 所述 模本二维数组取材于糖尿病病情判定标准， 该判定标准是国际卫生组织（WHO)和中华糖 尿病学会承认并颁发的最新糖尿病标准， 由 "亚太地区 2型糖尿病政策组" 发表于他们 2002年编辑出版的 《2型糖尿病实用目标与治疗》 中。 该手册经中华糖尿病学会批准并 翻译出版， 是最新关于糖尿病的权威性的文件。 本发明参考该判定标准， 并进行了合理 的排列和组合， 将取样方式分为静脉取血和毛细血管取血， 取样时间分为空腹血糖、 餐 后 2小时血糖、 服糖后 2小时血糖和随机血糖， 将每种血糖值划分为 4〜5个数值范围， 由此产生 400多种血糖值组合。 本发明根据临床经验， 筛选出有实际价值的近 100种血 糖值组合， 以及根据上述组合归纳的 5种糖尿病病情信息。 因此， 所述模本二维数组是 由近 100个血糖值数组和 5种糖尿病病情信息组合而成。 推理单元 131每接收一组血糖 值数组， 便在上述模本二维数组中搜索与该血糖值数组对应的最接近的模本二维数组的 血糖值， 从而得到所对应的糖尿病病情信息。
考虑到推理单元 131接收的血糖值数组组成的不确定性， 本发明在上述 5种病情信 息的基础上， 又增加了补充数据信息。 当推理单元 131接收的血糖值数组不足以得出病 情信息时， 给出 "信息不足"或 "应补充血糖值"等信息。 例如， 如果推理单元 131接 收的血糖值数组为： 空腹血糖 6. 6 纖。1/1、 餐后 2小时血糖 8. 5 mmol/l， 由于该血糖值 数组数据不充分， 因此推理单元 131给出 "需要服糖后 2小时数据" 的提示。 如果推理 单元 131接收的血糖值数组为 '· 空腹血糖 6. 6 mmol/1, 服糖后 2小时血糖 8. 5 mmol/1, 推理单元 131将给出 "糖耐量低减" 的糖尿病病情信息。 图 2所示的知识库系统模块 13 的工作流程可以进一步说明知识库系统模块 13的技术方案。
知识库系统模块 13可由硬件芯片或软件程序实现， 优选方案采用单片机 MCU。 借助 单片机 MCU的强大功能， 本发明还可实现其他功能， 如：
( 1 ) 储存糖尿病治疗数据库， 提供糖尿病的治疗信息供患者参考；
(2) 设置报警器， 当患者糖尿病病情严重到设定程度时， 发出声和 /或光报警；
(3) 设置通讯接口， 传送糖尿病病情信息或接收相关文件。
图 3为本发明糖尿病监测仪另一技术方案的结构示意图。 如图 3所示， 本发明糖尿 病监测仪包括依次连接的输入模块 11、 储存模块 12、 数据传输模块 24和显示模块 14。 输入模块 11负责采集患者血糖值， 并发送到储存模块 12储存。所述输入模块 11可以采 用常规的血糖检测装置， 如市场上销售的各种血糖检测仪。储存模块 12所储存的血糖值 是血糖值数组， 所述血糖值数组是由不同类别的血糖值组成。 在本实施例中， 患者的血 糖值按取样方式和 /或按取样时间分类， 取样方式分为静脉取血和毛细血管取血， 取样时 间分为空腹血糖、 餐后 2小时血糖、 服糖后 2小时血糖和随机血糖。 具体地说， 血糖值 数组是由上述各种血糖值任意组合、 按设定格式排列的数组。
本发明技术方案的核心是设置了与储存模块 12和显示模块 14连接的数据传输模块
24, 所述数据传输模块 24通过数据通讯与外设的知识库系统模块 13连接。 所述数据传 输模块 24向知识库系统模块 13传送从储存模块 12接收的血糖值数组， 同时从知识库系 统模块 13接收糖尿病病情信息，传送到显示模块 14显示和 /或传送到存储模块 12存储。 具体地说， 本发明的技术方案与前述技术方案的区别在于， 本发明的知识库系统模块 13 被设置在外部， 与数据传输模块 24通过数据通讯建立信息传递关系。 '
外设的知识库系统模块 13的结构和工作原理与前述基本相同，所述糖尿病病情信息 包括血糖正常、 低血糖、 糖耐量低减、 空腹血糖受损和糖尿病。
所述数据传输单元 24可以是无线通讯终端或网络通讯终端或数据接口。
所述无线通讯终端是指利用移动通讯网络进行数据传输的设备，在这里指短信终端， 如手机。 在此优选方案中， 短信终端和知识库系统模块 13通过移动通讯网络互联， 短信 终端将血糖值数组按短消息方式发送给知识库系统模块 13,知识库系统模块 13的进行推 理判断后， 将糖尿病病情信息同样以短消息方式发送回短信终端， 短信终端将糖尿病病 情信息传送到显示模块 14显示和 /或传送到存储模块 12存储。
所述网络通讯终端是指利用 INTERNET网络进行数据传输的设备，这里指即时通讯终 端， 如笔记本。 在优选方案中， 即时通讯终端和知识库系统模块 13通过 INTERNET网络 互联， 即时通讯终端将血糖值数组按即时消息方式发送给知识库系统模块 13， 知识库系 统模块 13进行推理判断后，将糖尿病病情信息同样以即时消息方式发送回即时消息终端， 即时通讯终端将糖尿病病情信息传送到显示模块 14显示和 /或传送到存储模块 12存储。 所述即时通讯是计算机网络终端用户之间即时消息的发送与接收过程， 如微软公司 MSN。 当然， 使用 Email方式也可实现上述功能。
所述数据接口是指直接与计算机进行数据交换的设备， 如 I/O接口。 在此优选方案 中， 存储知识库系统模块 13的计算机通过所述 I/O接口接收血糖值数组， 知识库系统模 块 13进行推理判断后， 糖尿病病情信息同样通过所述 I/O接口发送回显示模块 14显示 和 /或传送到存储模块 12存储。
应当指出， 以上所述具体实施方式可以使本领域技术人员更全面地理解本发明， 但 不以任何方式限制本发明。 因此， 对不脱离本发明精神和技术实质的技术方案及其改进， 均应涵盖在本发明专利的保护范围中。

Claims

权利要求书
1.一种糖尿病监测仪， 其特征在于， 包括依次连接的输入模块、 储存模块和知识库 系统模块， 所述储存模块从输入模块接收患者一种或一种以上血糖值， 按类别分别储存， 并发送给知识库系统模块， 所述知识库系统模块根据所述一种或一种以上血糖值推理出 糖尿病病情信息。
2.如权利要求 1所述的糖尿病监测仪， 其特征在于， 所述输入模块为测定患者血糖 值的血糖检测装置。
3.如权利要求 1所述的糖尿病监测仪， 其特征在于， 所述知识库系统模块还连接显 示模块， 显示所述血糖值数组和 /或所述糖尿病病情信息。
4.如权利要求 1所述的糖尿病监测仪， 其特征在于， 所述各种血糖值的区别在于取 血时间不同。
5.如权利要求 4所述的血糖值包括有空腹血糖值，与糖耐量试验时间有关的血糖值， 与用餐时间有关的血糖值， 和 /或上述三个血糖值以外的任何时间的血糖值。
6.如权利要求 5所述的与糖耐量试验时间有关的血糖值为糖耐量试验中服糖后 2小 时血糖值， 与用餐时间有关的血糖值为餐后 2小时的血糖值， 上述三个血糖值以外的任 何时间的血糖值叫做随机血糖值。
7.如权利要求 1〜5之一所述的糖尿病监测仪，其特征在于，所述知识库系统模块包 括依次连接的接收单元、 推理单元和发送单元， 推理单元还连接糖尿病知识库； 所述糖 尿病知识库为反映模本血糖值与糖尿病病情间对应关系的数组； 所述接收单元接收并储 存模块的各血糖值， 推理单元搜索所述糖尿病知识库数组， 并把所述糖尿病知识库中的 各组元的数据与接收的各血糖值进行比对， 并在所述糖尿病知识库中找到与接收的各血 糖值最接近的一个或一个以上的组元， 从而得到该血糖值对应的糖尿病病情信息， 发送 到显示模块显示和 /或存储模块储存。
8.一种糖尿病监测仪， 其特征在于， 包括依次连接的输入模块、 储存模块、 数据传 输模块和显示模块， 所述储存模块从输入模块接收患者血糖值， 按类别储存， 并发送给 数据传输模块； 所述数据传输模块还通过数据通讯与外设的知识库系统模块连接， 向知 识库系统模块发送血糖值， 同时从知识库系统模块接收糖尿病病情信息。
9.如权利要求 8所述的糖尿病监测仪， 其特征在于， 所述输入模块为测定患者血糖 值的血糖检测装置。
10.如权利要求 8所述的糖尿病监测仪， 其特征在于， 所述血糖值由不同类别的血糖 值组成， 所述类别为按取样时间分类； 取样时间为空腹血糖、 与糖耐量试验时间有关的 血糖值， 与用餐时间有关的血糖值， 和 /或上述三个血糖值以外的任何时间的血糖值。
U.如权利要求 10所述的与糖耐量试验时间有关的血糖值为糖耐量试验中服糖后 2 小时血糖值， 与用餐时间有关的血糖值为餐后 2小时的血糖值， 上述三个血糖值以外的 任何时间的血糖值叫做随机血糖值。
12.如权利要求 8〜11之一所述的糖尿病监测仪， 其特征在于， 所述外设的知识库系 统模块包括依次连接的接收单元、推理单元和发送单元， 推理单元还连接糖尿病知识库; 所述糖尿病知识库为反映模本血糖值与糖尿病病情间对应关系的数组， 所述接收单元接 收数据传输模块的各血糖值， 推理单元搜索所述糖尿病知识库数组并与所接收的数据进 行比对， 找到糖尿病知识库中与所接收的数据最接近的组元从而得到该血糖值对应的糖 尿病病情信息， 通过数据传输模块发送到显示模块显示和 /或存储模块储存
Π.如权利要求 8〜12之一所述的糖尿病监测仪， 其特征在于， 所述数据传输模块为 无线通讯终端、 网络通讯终端和 /或数据接口。
PCT/CN2006/000777 2005-04-27 2006-04-24 Dispositif pour controler le diabete WO2006114051A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/919,374 US20090312620A1 (en) 2005-04-27 2005-04-24 Diabetes monitor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB2005100116367A CN100394884C (zh) 2005-04-27 2005-04-27 糖尿病监测仪
CN200510011636.7 2005-04-27

Publications (1)

Publication Number Publication Date
WO2006114051A1 true WO2006114051A1 (fr) 2006-11-02

Family

ID=35048952

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2006/000777 WO2006114051A1 (fr) 2005-04-27 2006-04-24 Dispositif pour controler le diabete

Country Status (3)

Country Link
US (1) US20090312620A1 (zh)
CN (1) CN100394884C (zh)
WO (1) WO2006114051A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101261276B (zh) * 2008-04-17 2012-04-18 北京软测科技有限公司 糖尿病监测及诊治装置
CA3013247A1 (en) * 2008-07-18 2010-01-21 Boston Medical Center Corporation Diagnostics for membranous nephropathy
JP5388564B2 (ja) * 2008-12-22 2014-01-15 シスメックス株式会社 糖尿病診療支援システム、コンピュータプログラム、及び記録媒体
CN102024090A (zh) * 2009-09-14 2011-04-20 深圳市嘉实特科技有限公司 一种乙肝指标数据处理装置、检测设备及检测系统
CN102053158B (zh) * 2009-11-09 2013-11-27 财团法人资讯工业策进会 血糖分析系统及装置
CN104573301A (zh) * 2013-10-29 2015-04-29 东南大学附属中大医院 重症患者的血糖控制服务系统
CN104665840B (zh) * 2015-03-02 2017-11-21 桂林麦迪胜电子科技有限公司 无创血糖测量方法及指端测量探头
CN105528748A (zh) * 2015-06-16 2016-04-27 江苏德尔福医疗器械有限公司 血糖实时监测管理及治疗系统
WO2018119663A1 (zh) * 2016-12-27 2018-07-05 创新精密仪器有限公司 糖尿病检测方法及糖尿病检测系统
US11484210B1 (en) * 2019-06-20 2022-11-01 Waleed Bahaa El Deen Abdul Raheem Ahmed Methods and systems for early detection of diabetes and advising those considered pre diabetic or diabetic
CN112967769B (zh) * 2021-03-19 2023-01-24 上海国药医药零售有限公司 一种连锁药店糖尿病随访数据的数据处理和数据评估方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001221803A (ja) * 2000-02-09 2001-08-17 Omron Corp 糖代謝能力判定装置
CN1477941A (zh) * 2001-08-20 2004-02-25 ����˹ҽ�����޹�˾ 无线糖尿病管理装置及使用该装置的方法
GB2393356A (en) * 2002-09-18 2004-03-24 E San Ltd Remote patient monitoring system

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010023324A1 (en) * 1997-11-03 2001-09-20 Allan Pronovost Glucose detector and method for diagnosing diabetes
US6990365B1 (en) * 1998-07-04 2006-01-24 Edwards Lifesciences Apparatus for measurement of blood analytes
IL151720A0 (en) * 2000-03-29 2003-04-10 Univ Virginia Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data
US7395158B2 (en) * 2000-05-30 2008-07-01 Sensys Medical, Inc. Method of screening for disorders of glucose metabolism
US7440786B2 (en) * 2002-03-08 2008-10-21 Sensys Medical, Inc. Method and apparatus for presentation of noninvasive glucose concentration information
JP4289869B2 (ja) * 2002-11-06 2009-07-01 シスメックス株式会社 糖尿病診断支援システム
JP4547173B2 (ja) * 2004-03-17 2010-09-22 シスメックス株式会社 糖尿病診療支援システム

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001221803A (ja) * 2000-02-09 2001-08-17 Omron Corp 糖代謝能力判定装置
CN1477941A (zh) * 2001-08-20 2004-02-25 ����˹ҽ�����޹�˾ 无线糖尿病管理装置及使用该装置的方法
GB2393356A (en) * 2002-09-18 2004-03-24 E San Ltd Remote patient monitoring system

Also Published As

Publication number Publication date
CN1676093A (zh) 2005-10-05
CN100394884C (zh) 2008-06-18
US20090312620A1 (en) 2009-12-17

Similar Documents

Publication Publication Date Title
WO2006114051A1 (fr) Dispositif pour controler le diabete
Piwernetz et al. Monitoring the targets of the St Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative
Murray et al. Charlson Index is associated with one‐year mortality in emergency department patients with suspected infection
US7155371B2 (en) Measuring device with comment input function
US20170156642A1 (en) Information Processing Apparatus and User Terminal
CN101483690B (zh) 移动通讯终端及健康信息采集方法
JP2007537016A (ja) 測定器接続の自動検出、およびデータの転送を実施するための方法および装置
CN105260588A (zh) 一种健康守护机器人系统及其数据处理方法
CN104574245A (zh) 健康一体机
US20120143070A1 (en) Blood pressure detection method and an apparatus therefor
CN206672107U (zh) 全方位健康管理设备
CN112336379A (zh) 一种骨质疏松症数据收集与分析平台
KR102246064B1 (ko) 생체 정보의 표시 방법
TWI668664B (zh) Method for dynamically analyzing blood sugar level, system thereof and computer program product
TW201941215A (zh) 健康管理輔助系統及管理伺服器
CN204856498U (zh) 数字化心血管风险评估系统
WO2010083766A1 (zh) 健康信息系统、方法及对应装置、设备及试剂载体
JP2007292516A5 (zh)
CN113409926A (zh) 一种智能随访系统
CN113851214A (zh) 一种基于家用机器人的科技自助体检方法
Chen et al. Validation of the Grandway MD2301 digital automatic blood pressure monitor according to the European Society of Hypertension International Protocol
CN111105853A (zh) 一种医院-社区-家庭三位一体的慢性病健康管理系统
Kim et al. A Smartphone-Based Near-Vision Testing System: Design, Accuracy, and Reproducibility Compared With Standard Clinical Measures
CN116602668B (zh) 一种全自动智能血糖检测系统
CN102657511A (zh) 一种具有数码视标和语音识别特征的视觉测量系统

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11919374

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06741710

Country of ref document: EP

Kind code of ref document: A1